EUROAPI announced that it has entered into a Contract Manufacturing Organization (CMO) agreement with a global animal health company. As part of this collaboration, EUROAPI will supply its client with a key veterinary product. The total contract value is expected to range between EUR 130 million and 150 million, over the 2025-2029 period.
Market Closed -
Other stock markets
|
Pre-market 07:48:23 | |||
2.974 EUR | -1.91% |
|
2.961 | -0.44% |
06-18 | Euroapi: CDMO agreement with Priothera in oncology | CF |
06-07 | EuroAPI appoints mediator to help restructure pile of debt, shares drop | RE |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-48.10% | 304M | |
+52.70% | 801B | |
+41.58% | 631B | |
-4.86% | 359B | |
+21.96% | 337B | |
+11.47% | 305B | |
+17.72% | 245B | |
+4.46% | 231B | |
+13.13% | 219B | |
+10.46% | 171B |
- Stock Market
- Equities
- EAPI Stock
- News EUROAPI
- EUROAPI Enters into Contract Manufacturing Organization Agreement with Global Animal Health Company